Literature DB >> 9285494

Recent progress in advanced glycation end products and diabetic complications.

H Vlassara1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285494     DOI: 10.2337/diab.46.2.s19

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  46 in total

1.  Salivary lysozyme and prevalent coronary heart disease: possible effects of oral health on endothelial dysfunction.

Authors:  Sok-Ja Janket; Jukka H Meurman; Pekka Nuutinen; Markku Qvarnström; Martha E Nunn; Alison E Baird; Thomas E Van Dyke; Judith A Jones
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02       Impact factor: 8.311

2.  Changes in glycoprotein components in streptozotocin--nicotinamide induced type 2 diabetes: influence of tetrahydrocurcumin from Curcuma longa.

Authors:  Leelavinothan Pari; Pidaran Murugan
Journal:  Plant Foods Hum Nutr       Date:  2007-01-17       Impact factor: 3.921

3.  Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells.

Authors:  Natalia Mercer; Hafiz Ahmed; Susana B Etcheverry; Gerardo R Vasta; Ana Maria Cortizo
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

4.  PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN?

Authors:  Jun Chen; Hyeong-Cheon Park; Susann Patschan; Sergey V Brodsky; Olga Gealikman; Mei-Chuan Kuo; Houwei Li; Francesco Addabbo; Fung Zhang; Alberto Nasjletti; Steven S Gross; Michael S Goligorsky
Journal:  Drug Discov Today Ther Strateg       Date:  2007

Review 5.  Diabetic neuropathy part 1: overview and symmetric phenotypes.

Authors:  Mamatha Pasnoor; Mazen M Dimachkie; Patricia Kluding; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-03-15       Impact factor: 3.806

Review 6.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

7.  Enhancement of glyoxalase 1, a polyfunctional defense enzyme, by quercetin in the brain in streptozotocin-induced diabetic rats.

Authors:  Xia Zhu; Ya-Qin Cheng; Qian Lu; Lei Du; Xiao-Xing Yin; Yao-Wu Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-30       Impact factor: 3.000

Review 8.  Diabetic complications and dysregulated innate immunity.

Authors:  Dana T Graves; Rayyan A Kayal
Journal:  Front Biosci       Date:  2008-01-01

9.  Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature.

Authors:  L Rodríguez-Mañas; J Angulo; S Vallejo; C Peiró; A Sánchez-Ferrer; E Cercas; P López-Dóriga; C F Sánchez-Ferrer
Journal:  Diabetologia       Date:  2003-03-12       Impact factor: 10.122

10.  Glycosylated human oxyhaemoglobin activates nuclear factor-kappaB and activator protein-1 in cultured human aortic smooth muscle.

Authors:  Concepcion Peiro; Nuria Matesanz; Julian Nevado; Nuria Lafuente; Elena Cercas; Veronica Azcutia; Susana Vallejo; Leocadio Rodriguez-Manas; Carlos F Sanchez-Ferrer
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.